2667-0267

JID Innovations

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 457 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact457 DOIs
2

Attach ORCID iDs across 87 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact87 DOIs
3

Deposit reference lists for 59 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact59 DOIs

DOIs for this ISSN

Showing the top 5 of 457 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Transcriptomic Profiling of Plaque Psoriasis and Cutaneous T… (10.1016/j.xjidi.2021.100094)
Abstract ORCID
66.11 20
2 Cytosine Deaminase Base Editing to Restore COL7A1 in Dystrop… (10.1016/j.xjidi.2023.100191)
Abstract ORCID
62.76 17
3 Type 2 Inflammation Contributes to Skin Barrier Dysfunction… (10.1016/j.xjidi.2022.100131)
Abstract
58.76 223
4 Deep Learning in Dermatology: A Systematic Review of Current… (10.1016/j.xjidi.2022.100150)
Abstract
52.25 122
5 A Series of BRAF- and NRAS-Driven Murine Melanoma Cell Lines… (10.1016/j.xjidi.2021.100076)
Abstract ORCID
52.07 10
6 Epidemiology of Pemphigus (10.1016/j.xjidi.2021.100004)
Abstract
51.70 116
7 The Relapse of Psoriasis: Mechanisms and Mysteries (10.1016/j.xjidi.2022.100116)
Abstract
49.21 92
8 Optimal Use of Jak Inhibitors and Biologics for Atopic Derma… (10.1016/j.xjidi.2023.100195)
Abstract
48.73 88
9 A Literature Review of Real-World Effectiveness and Safety o… (10.1016/j.xjidi.2021.100042)
Abstract
47.16 76
10 Emerging Roles of Adipose Tissue in the Pathogenesis of Psor… (10.1016/j.xjidi.2021.100064)
Abstract
43.31 53
11 Seeing through the Skin: Photoacoustic Tomography of Skin Va… (10.1016/j.xjidi.2021.100039)
Abstract
42.47 49
12 Defining a Unique Gene Expression Profile in Mature and Deve… (10.1016/j.xjidi.2023.100211)
Abstract ORCID
42.25 6
13 Evolution of Transdermal Drug Delivery Devices and Novel Mic… (10.1016/j.xjidi.2023.100225)
Abstract
42.25 48
14 Sunscreens with the New MCE Filter Cover the Whole UV Spectr… (10.1016/j.xjidi.2021.100070)
Abstract
40.58 41
15 Restoring Prohealing/Remodeling-Associated M2a/c Macrophages… (10.1016/j.xjidi.2022.100138)
Abstract
40.58 41
16 Identification of Keratinocyte Mitogens: Implications for Hy… (10.1016/j.xjidi.2021.100066)
Abstract
40.32 40
17 Cytokine RNA In Situ Hybridization Permits Individualized Mo… (10.1016/j.xjidi.2021.100021)
Abstract
39.78 38
18 Automatic SCOring of Atopic Dermatitis Using Deep Learning:… (10.1016/j.xjidi.2022.100107)
Abstract
39.78 38
19 Frontiers in Lichen Planopilaris and Frontal Fibrosing Alope… (10.1016/j.xjidi.2022.100113)
Abstract
39.78 38
20 Cannabinoids for the Treatment of Dermatologic Conditions (10.1016/j.xjidi.2022.100095)
Abstract
39.21 36
21 Hidradenitis Suppurativa: Host-Microbe and Immune Pathogenes… (10.1016/j.xjidi.2021.100001)
Abstract
38.91 35
22 Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell… (10.1016/j.xjidi.2021.100003)
Abstract
38.91 35
23 Ninjurin1 Deletion in NG2-Positive Pericytes Prevents Microv… (10.1016/j.xjidi.2022.100141)
Abstract ORCID
38.91 5
24 Cutaneous Hypervascularization Treatment Using Photo-Mediate… (10.1016/j.xjidi.2023.100237)
Abstract ORCID
38.91 5
25 Characterization of Human Keratinocyte Cell Lines for Barrie… (10.1016/j.xjidi.2021.100018)
Abstract
38.60 34
26 IL-34 Downregulation‒Associated M1/M2 Macrophage Imbalance I… (10.1016/j.xjidi.2022.100112)
Abstract
38.60 34
27 Peroxisomal Fatty Acid Oxidation and Glycolysis Are Triggere… (10.1016/j.xjidi.2021.100033)
Abstract
37.96 32
28 Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refra… (10.1016/j.xjidi.2021.100067)
Abstract
37.96 32
29 Nanoparticles as a Therapeutic Delivery System for Skin Canc… (10.1016/j.xjidi.2023.100197)
Abstract
37.28 30
30 Applications of Laser Speckle Contrast Imaging Technology in… (10.1016/j.xjidi.2023.100187)
Abstract
36.93 29
31 Expanding Personalized, Data-Driven Dermatology: Leveraging… (10.1016/j.xjidi.2022.100105)
Abstract
35.78 26
32 Erratum (10.1016/j.xjidi.2022.100149)
Abstract References ORCID
35.78 2
33 Training Physician‒Scientists: A Call for a Cultural Shift i… (10.1016/j.xjidi.2021.100093)
Abstract ORCID
34.95 4
34 Effective Peer Review: Who, Where, or What? (10.1016/j.xjidi.2022.100162)
Abstract ORCID
34.95 4
35 M1/M2 Macrophage Skewing is Related to Reduction in Types I,… (10.1016/j.xjidi.2023.100222)
Abstract
34.95 24
36 Nuclear and Urinary Measurements Show the Efficacy of Sun-Pr… (10.1016/j.xjidi.2023.100227)
Abstract ORCID
34.95 4
37 Advances in Pemphigus and Pemphigoid: A Report of the Intern… (10.1016/j.xjidi.2024.100339)
Abstract References
34.95 4
38 Understanding the Gut Microbiota in Pediatric Patients with… (10.1016/j.xjidi.2021.100051)
Abstract
34.04 22
39 Deletion of TNFAIP6 Gene in Human Keratinocytes Demonstrates… (10.1016/j.xjidi.2021.100054)
Abstract
33.56 21
40 Multiomic Analysis of the Gut Microbiome in Psoriasis Reveal… (10.1016/j.xjidi.2022.100115)
Abstract
33.56 21
41 Safety and Efficacy of Ritlecitinib and Brepocitinib in Alop… (10.1016/j.xjidi.2022.100156)
Abstract
33.56 21
42 Age-Related Downregulation of CCN2 Is Regulated by Cell Size… (10.1016/j.xjidi.2022.100111)
Abstract
33.06 20
43 SB206, a Nitric Oxide–Releasing Topical Medication, Induces… (10.1016/j.xjidi.2021.100019)
Abstract
31.97 18
44 Oncogenic Mutations and Gene Fusions in CD30-Positive Lympho… (10.1016/j.xjidi.2021.100034)
Abstract
31.97 18
45 Structural Basis for p19 Targeting by Anti–IL-23 Biologics:… (10.1016/j.xjidi.2024.100261)
Abstract
31.97 18
46 T-Cell Adhesion in Healthy and Inflamed Skin (10.1016/j.xjidi.2021.100014)
Abstract
31.38 17
47 Evidence-Based Consensus Recommendations for the Evolving Tr… (10.1016/j.xjidi.2021.100045)
Abstract
31.38 17
48 The Use of Single-Cell RNA-Sequencing and Spatial Transcript… (10.1016/j.xjidi.2023.100198)
Abstract
31.38 17
49 Reliable Detection of Eczema Areas for Fully Automated Asses… (10.1016/j.xjidi.2023.100213)
Abstract
31.38 17
50 Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα… (10.1016/j.xjidi.2023.100214)
Abstract
31.38 17